[1]
Magen, I. et al. 2025. JAK1 Inhibition with Upadacitinib in a Patient with Refractory Severe Chronic Spontaneous Urticaria and Concomitant Rheumatoid Arthritis: Complete Resolution of Urticaria and Remission of Rheumatoid Arthritis. Acta Dermato-Venereologica. 105, (Sep. 2025), adv44312. DOI:https://doi.org/10.2340/actadv.v105.44312.